A phase II, open, randomized, multicentre study evaluating in healthy children 12-24 months of age, the safety and immunogenicity of GlaxoSmithKline Biologicals' combined Measles-Mumps-Rubella-Varicella vaccine (MeMuRu-OKA), compared to GlaxoSmithKline Biologicals' Varicella vaccine

Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.

Vivli是一家独立的非营利组织，其打造了一套全球性数据共享与分析平台，服务于国际科研共同体的各类主体。该组织的使命在于通过构建并落地可持续的全球数据共享事业体系，推动、协调并促进临床研究数据的科学共享与复用。Vivli平台涵盖独立数据存储库（data repository）、深度搜索引擎以及基于云端的安全分析平台。